WallStreetZenWallStreetZen

NASDAQ: CMPX
Compass Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CMPX

Based on 2 analysts offering 12 month price targets for Compass Therapeutics Inc.
Min Forecast
$8.00+290.24%
Avg Forecast
$9.00+339.02%
Max Forecast
$10.00+387.8%

Should I buy or sell CMPX stock?

Based on 2 analysts offering ratings for Compass Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CMPX stock forecasts and price targets.

CMPX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2024-03-21

1 of 1

Forecast return on equity

Is CMPX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is CMPX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CMPX revenue forecast

What is CMPX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$33.0M
Avg 2 year Forecast
$126.6M
Avg 3 year Forecast
$225.3M

CMPX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CMPX$2.05$9.00+339.02%Buy
IMMP$2.39N/AN/A
XERS$2.04$5.00+145.10%Strong Buy
IPSC$4.27$18.50+333.26%Strong Buy
CDXC$3.67$6.00+63.49%Buy

Compass Therapeutics Stock Forecast FAQ

Is Compass Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CMPX) stock is to Buy CMPX stock.

Out of 2 analysts, 0 (0%) are recommending CMPX as a Strong Buy, 2 (100%) are recommending CMPX as a Buy, 0 (0%) are recommending CMPX as a Hold, 0 (0%) are recommending CMPX as a Sell, and 0 (0%) are recommending CMPX as a Strong Sell.

If you're new to stock investing, here's how to buy Compass Therapeutics stock.

What is CMPX's revenue growth forecast for 2025-2027?

(NASDAQ: CMPX) Compass Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Compass Therapeutics's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast CMPX's revenue for 2025 to be $4,541,818,535, with the lowest CMPX revenue forecast at $4,419,364,173, and the highest CMPX revenue forecast at $4,664,272,897. On average, 5 Wall Street analysts forecast CMPX's revenue for 2026 to be $17,412,459,947, with the lowest CMPX revenue forecast at $5,324,700,918, and the highest CMPX revenue forecast at $30,185,688,226.

In 2027, CMPX is forecast to generate $31,004,756,561 in revenue, with the lowest revenue forecast at $16,758,361,028 and the highest revenue forecast at $51,040,629,231.

What is CMPX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CMPX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CMPX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CMPX price target, the average CMPX price target is $9.00, with the highest CMPX stock price forecast at $10.00 and the lowest CMPX stock price forecast at $8.00.

On average, Wall Street analysts predict that Compass Therapeutics's share price could reach $9.00 by Mar 22, 2025. The average Compass Therapeutics stock price prediction forecasts a potential upside of 339.02% from the current CMPX share price of $2.05.

What is CMPX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CMPX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.